Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
Davis SE, Cook AK, Hall JA, Voskobiynyk Y, Carullo NV, Boyle NR, Hakim AR, Anderson KM, Hobdy KP, Pugh DA, Murchison CF, McMeekin LJ, Simmons M, Margolies KA, Cowell RM, Nana AL, Spina S, Grinberg LT, Miller BL, Seeley WW, Arrant AE. Davis SE, et al. Acta Neuropathol Commun. 2023 Apr 28;11(1):70. doi: 10.1186/s40478-023-01571-4. Acta Neuropathol Commun. 2023. PMID: 37118844 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 39751337
Impact of HIV-1 tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 tat transgenic mice.
Zhu J, Cirincione AB, Strauss MJ, Davis SE, Eans SO, Tribbitt DK, Alshakhshir N, McLaughlin JP. Zhu J, et al. Among authors: davis se. Eur J Pharmacol. 2024 Dec 5;984:177030. doi: 10.1016/j.ejphar.2024.177030. Epub 2024 Oct 2. Eur J Pharmacol. 2024. PMID: 39366503
Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV.
Jimenez-Torres AC, Hastie JA, Davis SE, Porter KD, Lei B, Moukha-Chafiq O, Zhang S, Nguyen TH, Ananthan S, Augelli-Szafran CE, Zhu J. Jimenez-Torres AC, et al. Among authors: davis se. J Pharmacol Exp Ther. 2024 Sep 16:JPET-AR-2024-002138. doi: 10.1124/jpet.124.002138. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 39284625 Free article.
194 results